23rd Annual Conference of BHIVA Presentations - Wednesday 5 April 2017

Date: 4 - 7 April 2017

Venue: Arena and Convention Centre, Liverpool

Presentations

Please view and download conference presentations by clicking on the links below:

BHIVA Review Session

Dr Matthew Page Dr Steve Taylor Translating recent research into clinical practice
Dr Matthew Page and Dr Steve Taylor, Birmingham Heartlands Hospital

Welcome Address by the Chair of the British HIV Association

Professor Chloe Orkin Professor Chloe Orkin
Barts Health NHS Trust, London

BHIVA Invited Lecture 1

Dr Philip Gothard Travellers with HIV: what to take, what will you bring back?
Dr Philip Gothard, University College London Hospitals NHS Foundation Trust

BHIVA Lunchtime Workshop 1 - Clinico-pathological case presentations

A lump in the neck
Dr Emily Clarke, Solent NHS Trust, Portsmouth

A fortitudinous diagnosis in an HIV- positive man
Dr Stephanie Wilmore, Royal Free London NHS Foundation Trust

Light at the end of the tunnel
Dr Owen Seddon, University Hospital of Wales, Cardiff

BHIVA Lunchtime Workshop 2 - UK-CAB Workshop

NHS sustainability and transformation plans: financial restrictions and their effects on HIV clinical care
Professor Simon Barton, Chelsea and Westminster Hospital, London

NHS sustainability and transformation plans: financial restrictions and their effects on HIV clinical care
Dr JS Bamrah, British Medical Association

MRC Clinical Trials Unit Session

The motion: This house believes that efavirenz should remain as an option to treat HIV in the UK

Dr Sarah Pett For the motion: Dr Sarah Pett
MRC Clinical Trials Unit, London

Dr Alejandro Arenas-Pinto Against the motion: Dr Alejandro Arenas-Pinto
MRC Clinical Trials Unit, London

Oral Research Presentations: Session 1: Antiretroviral Therapy

Miss Amy Moore Abstract O1: Safety of switching raltegravir 400mg twice daily to raltegravir 800mg once daily in virologically suppressed patients
Miss Amy Moore, Chelsea and Westminster Hospital NHS Foundation Trust, London

Dr Joseph Custodio Abstract O2: Clinical pharmacology of the HIV integrase strand transfer inhibitor bictegravir
Dr Joseph Custodio, Gilead Sciences Ltd

Dr Daniela Kirwan Abstract O3: Integrase inhibitor resistance in HIV-positive patients undergoing routine testing: frequency and clinical implications
Dr Daniela Kirwan, Public Health England

Dr Nicola Mackie Abstract O4: Timing of detection of treatment-emergent resistance during rebound viraemia
Dr Nicola Mackie, Imperial College Healthcare NHS Trust, London

Dr Hardeep Kang Abstract O5: Patient’s perceptions of switching from Atripla to generic Truvada and efavirenz
Dr Hardeep Kang, Blackpool Teaching Hospitals NHS Foundation Trust

Miss Venita Hardweir Abstract O6: The next generiction update
Miss Venita Hardweir, Brighton and Sussex University Hospitals NHS Trust

BHIVA Plenary Session 1 - HIV training and the launch of the new internal medicine curriculum

Dr Alastair Miller Changes to postgraduate specialty training and the introduction of the new internal medicine curriculum
Dr Alastair Miller, Joint Royal Colleges of Physicians Training Board

Dr Rak Nandwani HIV training in the dually accredited Internal Medicine and GUM curriculum
Dr Rak Nandwani, NHS Greater Glasgow and Clyde

Professor Martin Wiselka The impact of the changes on common infection training
Professor Martin Wiselka, University Hospitals of Leicester NHS Trust

Dr Emily Lord How those in training will be affected and what can be done to prepare for the future
Dr Emily Lord, Oxford University Hospitals NHS Foundation Trust

BHIVA Keynote Lecture

Dr Valerie Delpech Towards elimination of HIV amongst gay and bisexual men in the United Kingdom
Dr Valerie Delpech, Public Health England

Dr Monica Desai Towards elimination of HIV amongst gay and bisexual men in the United Kingdom
Dr Monica Desai, Public Health England

Welcome Reception